Metric Finance
LearnFAQ
LearnFAQ

Learn / RVMDW

NASDAQ: RVMDW

Revolution Medicines (RVMDW) stock, explained like you're 5

Revolution Medicines trades on the Nasdaq under the ticker RVMDW. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 2.1 billion dollars.

Ticker
RVMDW
Exchange
Nasdaq
Sector
Healthcare
Industry
Biological Products (No Diagnostic Substances)
Size
Mid cap, about 2.1 billion dollars

Is Revolution Medicines a small, medium or large cap company?

No. Revolution Medicines is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 2.1 billion dollars.

Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.

How Revolution Medicines makes money

  • Selling medicines, medical devices or healthcare services.
  • Insurance premiums or hospital and clinic fees.
  • Research and licensing deals.

What moves RVMDW stock

  • Results from clinical trials and approvals from regulators.
  • Drug prices, insurance rules and government policy.
  • Patents running out and new competing treatments.

In the news lately

  • Revolution Medicines Stock In Focus After EU Drug Backing (Yahoo Finance)
  • Revolution Medicines (RVMD) Could Be 31% Below Fair Value Following EU RASONQUE Backing (Simply Wall Street)
  • What's Going On With Revolution Medicines Stock Friday? Revolution Medicines (NASDAQ:RVMD) (Benzinga)
  • Why Moderna Stock, Novavax, and Revolution Medicines Are Slumping Today (Barron's)
  • A pancreatic cancer drug cut the risk of death by 60% versus chemotherapy in a trial. (Stock Titan)

Follow RVMDW in your daily brief

Each trading day at 5 PM ET we post what happened to Revolution Medicines and why it matters, in simple words. Free.

Start my free brief

Key terms to know before you follow RVMDW

  • Market cap
  • P/E ratio
  • EPS (earnings per share)
  • Earnings report
  • Volatility

Questions about Revolution Medicines stock

What does Revolution Medicines do?

Revolution Medicines trades on the Nasdaq under the ticker RVMDW. It is a mid cap company in the biological products (no diagnostic substances) industry, part of the healthcare sector, with a market value of about 2.1 billion dollars.

What is the ticker symbol for Revolution Medicines?

Revolution Medicines trades under the ticker RVMDW on the Nasdaq.

What is Revolution Medicines's market cap?

Revolution Medicines is a mid cap stock with a market cap of about 2.1 billion dollars.

How does Revolution Medicines make money?

Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.

What moves RVMDW stock?

Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.

How can I follow RVMDW stock every day?

Add RVMDW to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.

Follow RVMDW daily

A free brief on Revolution Medicines and your other stocks, every trading day at 5 PM ET.

Start my free brief

Similar stocks

  • ARGX · Argenx SE
  • RVMD · Revolution Medicines
  • BNTX · BioNTech SE
  • EXEL · Exelixis

Similar stocks

  • ARGXArgenx SE
  • RVMDRevolution Medicines
  • BNTXBioNTech SE
  • EXELExelixis

Compare RVMDW: RVMDW vs ARGX, RVMDW vs RVMD, RVMDW vs BNTX

Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.

Metric Finance

Stocks explained like you're 5.

Product

  • Learn
  • FAQ
  • Your account

Legal

  • Privacy
  • Terms

Support

  • Contact
  • Unsubscribe

© 2026 Metric Finance

Built by Yashna & Vansh · Not investment advice · Market data may be delayed